Steatotische Lebererkrankung mit metabolischer Funktionsstörung – die neue Nomenklatur zur Fettleber im deutschen Kontext

Schlüsselwörter

NASH - Nomenclature - Fettleber - MASLD - Stigma

• Literatur

• 1 Huber Y, Schulz A, Schmidtmann I. et al. Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in Germany. Hepatol Commun 2022; 6: 1457-1466
• 2 Liebe R, Esposito I, Bock HH. et al. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol 2021; 74: 1455-1471
• 3 Roeb E, Canbay A, Bantel H. et al. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol 2022; 60: 1346-1421
• 4 Staufer K, Huber-Schonauer U, Strebinger G. et al. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. J Hepatol 2022; 77: 918-930
• 5 Loria P, Lonardo A, Carulli N. Should nonalcoholic fatty liver disease be renamed?. Dig Dis 2005; 23: 72-82
• 6 Beuers U, Gershwin ME, Gish RG. et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol 2015; 110: 1536-1538
• 7 Eslam M, Newsome PN, Sarin SK. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020; 73: 202-209
• 8 Rinella ME, Lazarus JV, Ratziu V. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023; 79 (06) 1542-1556